Abstract
It is essential in any method for radiolabeling antibody with99mTc that the labeling procedure is rapid and reliable, producing a highly stable99mTc-antibody complex with minimal effect on the immunoreactivity of the antibody. In the present study, analysis of the stability and homogeneity of radiolabeled (99mTc and125I) antibodies (HMFG1 and PR1A3) was carried out by fast protein liquid chromatography (FPLC) using superose-6 and S-200 columns, and by polyacrylamide gel electrophoresis (PAGE) followed by autoradiography.
Superose 6 and S-200 gel filtration analysis showed the radiolabel (99mTc or125I) eluting with a retention time identical to that of native antibody. No peaks of relative molecular size (Mr) corresponding to possible antibody fragments were seen in either the UV or the radioactive FPLC elution profiles. PAGE analysis of99mTc labeled antibody, however, revealed the presence of a number of radiolabeled antibody fragments (Mr<IgG) that were not detected by the same analysis of125I labeled antibody.
The stability of the radiolabeled antibodies in serum in vitro was also studied. FPLC (superose-6) analysis after 45 h incubation in normal serum in vitro revealed 3.3% (HMFG1), and 20% (PR1A3) of the99mTc on a molecule or aggregate with a Mr greater than that of IgG. There is also the appearance of small amounts of99mTc-labeled material with a Mr<IgG in the later fractions (2.2% for HMFG1 and 4.9% for PR1A3). Similar results were obtained using radioiodinated antibody, although the small amount of low molecular size material detected as a single peak with a longer retention time than the99mTc equivalent corresponds to free iodide.
Similar content being viewed by others
References
Wong, D. W., Mishkin, F., and Lee, T. (1979) A rapid chemical method of labeling human plasma proteins with99mTc-pertechnetate at pH 7.4.Int. J. Nucl. Med. Biol. 20, 967–972.
Pettit, W. A., Deland, F. H., Bennett, S. J., et. al. (1980) Improved protein labeling by stannous tartrate reduction of pertechnetate.J. Nucl. Med. 21, 59–62.
Sundrehage, E. (1982) Formation of99mTc-immunoglobulin G complexes free from radiocolloids, quality controlled by radioimmunoelectrophoreses.Eur. J. Nucl. Med. 7, 549–552.
Tolman, G. L., Hadjian, R. J., Morelock, M. M., et al. (1984)In vivo tumour localization of technetium-labeled metallothionein/monoclonal antibody conjugates.J. Nucl. Med. 25, 20 (abstract).
Childs, R. L. and Hnatowich, D. J. (1985) Optimum conditions for labeling of DTPA coupled antibodies with99mTechnetium.J. Nucl. Med. 26, 293–299.
Paik, C. H., Pham, L. N. B., Hong, J. J., et al. (1985) The labeling of highaffinity sites of antibodies with99mTc.Int. J. Nucl. Med. Biol. 12, 3–8.
Arano, Y., Yokoyama, A., and Magata, H. (1986) Synthesis and evaluation of a new bifunctional chelating agen for99mTc labelling proteins: P-carboxyethyl-phenyl-glyoxaldi-(N-methylthiosemicarbazone).Int. J. Nucl. Med. Biol. 12, 425–430.
Fritzberg, A. R., Kasina, S., Reno, J. M., et al. (1986) Radiolabeling of antibodies with99mTc using N2S2 ligands.J. Nucl. Med. 27, 957, 958.
Rhodes, B. A., Zamora, P. O., Newell, K. D. et al. (1986)99mTechnetium labeling of murine monoclonal antibody fragments.J. Nucl. Med. 27, 685–693.
Schwarz, A. and Steinstrasser, A. (1987) A novel approach to Tc-99m labelled monoclonal antibodies (abstract).J. Nucl. Med. 28, 72.
Kinder, K. E., Wen, M. D., Nowotnik, D. P., et al. (1991) Technetium labeling of monoclonal antibodies with functionalised BATOs: 2. TcCl(DMG)3CPITC labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab’)2.Bioconjugate Chemistry 2, 407–414.
Najafi, A., Aluddin, M. M., Siegel, M. E., et. al. (1991) Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclides.Nucl. Med. Biol. 18, 179–185.
Mather, S. J. and Ellison, D. (1990) Reduction-mediated technetium-99m labelling of monoclonal antibodies.J. Nucl. Med. 31, 692–697.
Granowska, M., Mather, S. J., Britton, K. E., et al. (1990)99mTc radioimmunoscintigraphy of colorectal cancer.Br. J. Cancer 62 (Suppl. X.), 30–33.
Taylor-Papadimitriou, J., Peterson, J. A., Arklie, J., et. al. (1981) Monoclonal antibodies to epithelium specific components of the milk fat globule membrane: production and reations with cells in culture.Int. J. Cancer 28, 17–21.
Richman, P. I., and Bodmer, W. F. (1987) Monoclonal antibodies to human colorectal epithelium, markers for differentiation and tumour characterisation.Int. J. Cancer 39, 317–328.
Fraker, P. J. and Speck, J. C., Jr. (1978) Protein and cell membrane iodinations with a sparingly soluble chloramide 1,3,4,6-tetrachloro-3a, 6a-diphenylglyoluril.Biochem. Biophys. Res. Commun. 80, 849–857.
Thakur, M. L., De Fulvio, J., Richard, M. D., et al. (1991) Technetium-99m labeled monoclonal antibodies: evaluation of reducing agents.Nucl. Med. Biol. 18, 227–233.